baber/WOPTO huggingface dataset:
Patent NZ-550438-A (NZ)
Title: Method and system for producing a building
Inventor: TADICH JOHN
Filed: 2006-10-10
Abstract: A method of building a building is disclosed. The method of building comprises the steps of: (a) building a roof structure of the building at ground level, where the roof structure includes a perimeter beam that extends around the periphery of the roof structure; (b) jacking the roof structure to a height above ground level by a plurality of jacks engaging jacking points on the perimeter beam; and (c) constructing a wall frame structure of the building beneath the roof structure after the roof structure has been jacked above ground level.
Patent NZ-551150-A (NZ)
Title: Scannable article having a signature section with alignment bars
Inventor: SCHENCK KAREN E
IPC: G06K19/06
Filed: 2004-09-30
Abstract: An article scannable by a data capture device has an informational surface and a signature section disposed on the informational surface. The signature section has a signature area and at least two alignment bars. A first alignment bar is disposed at a first end of the signature section relative to writing direction. A second alignment bar is disposed at the end of the signature section opposite the first end. The first and second alignment bars are within the signature section. The two alignment bats have a predetermined dimension corresponding to a predetermined calibration dimension of the data capture device.
Patent NZ-552862-A (NZ)
Title: A topical analgesic composition
Inventor: SHEIL MEREDITH
Filed: 2006-03-15
Abstract: Disclosed is a topical analgesic composition for use on a significant open skin wound, said composition comprising at least one local anaesthetic agent and a carrier that adheres to the wound, forms a long-lasting viscous barrier over the wound, and promotes and prolongs contact of the anaesthetic agent with the wound such that the composition provides. An analgesic effect beyond that attributable to the anaesthetic agent alone whilst the barrier covers the skin wound, wherein said carrier comprises a hydrophilic or hydroalcoholic gelling agent, at least one type of gum or cellulosic preparation, or a polyhydric alcohol in combination with a cellulosic preparation, and wherein said composition further comprises one or more of an antiseptic agent, an insecticide, an insect repellent, a vasoconstrictor, a skin penetrating enhancer, an antioxidant, and a detectable marker for indicating the presence of the composition on the wound.
Patent NZ-554195-A (NZ)
Title: Restoring and collating system and method for 3-dimensional face data
Inventor: AOYAMA NORIMASA
IPC: G06F21/32
Filed: 2007-03-29
Abstract: A 3-dimensional face data restoring and collating system is provided. The system includes a 2-dimension face image storage unit configured to store a number of 2-dimensional face images of persons, a 3-dimensional face restored shape storage unit, and a 3-dimensional face shape restoring unit. The restoring unit is configured to restore a 3-dimensional face shape data from one of the 2-dimensional face images for a target, based on a 3-dimensional reference face shape data.
Patent NZ-555634-A (NZ)
Title: Adjustable bracket for securing vessel to surface with flexible straps and slidable portions in receiving track
Inventor: LARMONT JAMES
IPC: A62B25/00
Filed: 2005-11-30
Abstract: An adjustable bracket (10) for securing a vessel to a surface includes slidable portions (12) and receiving track (14) mounted on the surface. Each slidable portion (12) includes a track engaging portion (16) positioned within track (14), an outwardly extending portion (18) and a flexible member (34) attached to engaging portion (32). In use, slidable portions (12) are positioned adjacent opposing sides of the vessel and flexible members (34) are fastened around the vessel such that tension in flexible members (34) causes slidable portions (12) to be held in place upon track (14) by friction. The vessel may be a portable fire extinguisher or oxygen tank and the surface might be a wall.
Patent NZ-568832-A (NZ)
Title: Improved construction system, method and apparatus
Inventor: BLACK GREGORY JOHN
IPC: E04B1/35
Filed: 2006-12-15
Abstract: A construction system apparatus for erecting buildings and the like comprises a plurality of lifting rams 20 operatively coupled to a power source and a controller operatively coupled to the power source to control the lifting rams. A plurality of elongate, telescopic lifting rails 28 extending beneath a construction element or part thereof, such as conventional roof members 18, is also provided. Each lifting rail is coupled to at least one lifting ram of the plurality of lifting rams to elevate the construction element to a prescribed height.
Patent NZ-578849-A (NZ)
Title: Fused heterocyclic compounds as serotonin receptor modulators
Inventor: CHAI WENYING
IPC: A61P25/00
Filed: 2004-09-15
Abstract: Disclosed is a 1, 2 diazole compound having serotonin receptor modulating activity of formula (III) wherein the substituents are disclosed within the specification. Also disclosed is the use of a compound of formula (III) in the manufacture of a medicament for the treatment of CNS disorders and ocular disorders.
Patent NZ-579465-A (NZ)
Title: Fibre reinforced pre-cast concrete in-ground structures and methods of manufacture of the same
Inventor: HOLMES JOHN FRANCIS
IPC: C04B7/00
Filed: 2009-09-04
Abstract: Disclosed are cementitious (concrete) compositions containing hydraulic cement, aggregate, water, polycarboxylate dispersant and synthetic fibres made from thermoplastic polymers wherein the synthetic fibres comprise between 100g and 8kg of per cubic metre of the cementitious composition, and wherein in-ground structures, such as pits, cast from said cementitious compositions substantially exceed the requirements of AS3600 and AS5100.
Patent NZ-588379-A (NZ)
Title: Crystal of benzimidazole compound
Inventor: HASHIMOTO HIDEO
IPC: A61P1/04
Filed: 2009-03-09
Abstract: Disclosed is a crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole wherein the powder X-ray diffraction analysis pattern has characteristic peaks at interplanar spacings (d) of 10.06 plus/minus 0.2, 8.70 plus/minus 0.2, 6.57 plus/minus 0.2, 5.59 plus/minus 0.2 and 4.00 plus/minus 0.2 Angstrom. Also disclosed is a pharmaceutical agent comprising the crystal and the use of the crystal for the production of an agent for the prophylaxis or treatment of peptic ulcer, Zollinger-Ellison syndrome, gastritis, reflux esophagitis, symptomatic gastroesophageal reflux disease (Symptomatic GERD), Barrett's oesophagus, functional dyspepsia, gastric cancer, stomach MALT lymphoma, ulcer caused by a non-steroidal anti-inflammatory agent, or hyperacidity or ulcer due to postoperative stress; or an inhibitor of upper gastrointestinal haemorrhage due to peptic ulcer, acute stress ulcer, haemorrhagic gastritis or invasive stress.
Patent NZ-588578-A (NZ)
Title: A micro-organism test apparatus which senses the presence of micro organisms by the colour change in light passing through the apparatus
Inventor: SHARPIN ROSEMARY KATHERINE CAMERON
IPC: G01N33/48
Filed: 2005-06-23
Abstract: A micro-organism detection apparatus comprises an incubator at least partially surrounding a container receiving space capable of receiving a closed rigid substantially transparent fluid container with at least one light path through the container, at least one light source mounted on or in the incubator capable of transmitting light into the container, at least one light sensor mounted on or in the incubator and capable of detecting light of at least one colour frequency light band which has passed through at least part of the fluid from the at least one light source, stored information on a non-transient medium on the light changes over time measured in a similar closed container containing a sample of a known identified micro-organism, and a comparator capable of detecting light changes over time resulting from a sample in the container being incubated in the incubator, and comparing it with the stored information to determine the presence or absence of a particular micro-organism.
Patent NZ-594492-A (NZ)
Title: Sodium salt of 5-cyclopropyl-2-{ [2-(2,6- difluorophenyl)pyrimidin-5-yl]amino} benzoic acid as dhodh inhibitor
Inventor: DEBETHUNE LAURENT
IPC: A61K31/505
Filed: 2010-03-11
Abstract: 594492 Disclosed herein is a sodium salt of 5-cyclopropyl-2-2-{ [2-(2,6-difluorophenyl)pyrimidine)pyrimidin-5-yl]amino} benzoide acid (I) as a DHODH inhibitor; a pharmaceutical composition comprising said salt and one or more therapeutic agents selected selected from anti-TNF-alpha monoclonal antibodies, TNF-alpha Antagonists, calcineurin (PP-2B) Inhibitors / INS expression inhibitors, IL-1 receptor antagonists, anti-CD20 monoclonal antibodies, p38 Inhibitors, NF-kappaB (NFKB) activation inhibitors, dihydrofolate reductase (DHFR) inhibitors, JAK3 Inhibitors, MEK inhibitors, S1 P1 agonists, Interferons, inmunomodulators, and adenosine aminohydrolase inhibitors; and the use of said salt or pharmaceutical composition in the treatment of a pathological condition or disease susceptible to amelioration by inhibition of dihydroorotate dehydrogenase, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondilytis, multiple sclerosis, Wegener's granulomatosis, systemic lupus erythematosus, psoriasis and sarcoidosis.
Patent NZ-597270-A (NZ)
Title: Use of a pyrimidine nucleotide precursor for reducing side effects of a cytotoxic cancer chemotherapy agent
Inventor: VON BORSTEL REID W
IPC: A61P21/00
Filed: 2011-12-21
Abstract: ABSTRACT - 597270 The disclosure relates to the use of a pyrimidine nucleotide precursor selected from the group consisting of uridine, an acyl derivative of uridine, cytidine, and an acyl derivative of cytidine, preferably 2',3',5'-tri-O-acetyluridine, for manufacture of a medicament for reducing side effects of a cytotoxic cancer chemotherapy agent that is not a pyrimidine nucleoside analog, wherein the side effects of cytotoxic cancer chemotherapy are selected from the group consisting of peripheral neuropathy, chemotherapy-induced menopause, chemotherapy-associated fatigue, and depressed appetite.
Patent NZ-600122-A (NZ)
Title: Wire fencing roll lifting and spooling device attachable to the forks of a forklift
Inventor: STENHOUSE JAMIE
IPC: B65H16/10
Filed: 2012-05-22
Abstract: A wire roll lifting apparatus including a mounting platform having two spaced apart legs with a mounting base pivotally attached between the two legs; said legs are attachable to a forklift vehicle by the forks of the forklift; a support arm mounted or mountable to the mounting base, the mounting base moveable between a first position where the mounting base has a planar axis substantially in line with the planar axis of the legs and a second position wherein the mounting base is substantially perpendicular to the legs; and a lock means to lock the mounting base to one or both of the legs when the mounting base is in the first position; wherein the support arm is inserted into the wire roll with the mounting base in the second position and the support arm in a horizontal orientation and the wire roll is raised to a vertical orientation by reverse movement of the vehicle, lowering of the forklift and contact of the mounting base with the ground creating rotation of the mounting base to the first position with consequent movement of the support arm and wire roll to a vertical orientation.
Patent NZ-600365-A (NZ)
Title: Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
Inventor: PUSCHL ASK
IPC: A61K31/4196
Filed: 2010-12-15
Abstract: 600416 Disclosed are 5-bicycloheteroarylalkyl-3-phenyl-1,2,4-triazole derivatives as represented by the general formula (I), wherein: HET-1 is a heteroaromatic group of formula II containing from 2 to 4 nitrogen atoms, and which is preferably selected from [1,2,4]triazolo[1,5-a]pyridine, [1,2,4]triazolo[1,5-a]pyrimidine or [1,2,4]triazolo[1,5-a]pyrazine, and which may be optionally substituted; Q is phenyl, optionally substituted with one to five substituents, or a monocyclic 5-membered or 6-membered heteroaromatic group containing 1 or 2 heteroatoms; L is a linker selected from S-CH2, CH2-S, ethylene, ethenylene or ethynylene; R1 is selected from H, alkyl, alkylcycloalkyl, hydroxyalkyl, CH2CN, CH2C(O)NH2, arylalkyl or alkylheterocycloalkyl; and tautomers, pharmaceutically acceptable salts and polymorphic forms thereof. Important compounds include 8-methoxy-5-methyl-2-(5-phenyl-2H-[1,2,4]triazol-3-ylsulfanylmethyl)-[1,2,4]triazolo[1,5-a]pyridine, 8-methyl-2-[2-(2-methyl-5-phenyl-2H-[1,2,4]triazol-3-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyridine, 5,7-dimethyl-2-[2-(2-methyl-5-phenyl-2H-[1,2,4]triazol-3-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyrimidine, 5,8-dimethyl-2-[2-(2-methyl-5-phenyl-2H-[1,2,4]triazol-3-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyrazine, 3-{ 5-[2-(8-methoxy-5-methyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)-ethyl]-3-phenyl-[1,2,4]triazol-1-yl} -propionitrile and 3-{ 5-[2-(5,8-dimethyl-[1,2 ,4]triazolo[1,5-a]pyrazin-2-yl)-ethyl]-3-phenyl-[1,2,4]triazol-1-yl} -propylamine. Also disclosed is a pharmaceutical composition comprising a therapeutically effective amount of a compound as defined above, and one or more pharmaceutically acceptable carriers, diluents and excipients, for the treatment of a neurodegenerative or psychiatric disorder, alone or in combination with one or more neuroleptic agents such as sertindole, olanzapine, risperidone, quetiapine, aripiprazole, haloperidol, clozapine, ziprasidone and osanetant, including disorders such as Alzheimer's disease, multi-infarct dementia, alcoholic dementia or other drug-related dementia, dementia associated with intracranial tumors or cerebral trauma, dementia associated with Huntington's disease or Parkinson's disease, or AIDS related dementia, delirium, amnestic disorder, post-traumatic stress disorder, mental retardation, learning disorders, attention-deficit/hyperactivity disorder, age-related cognitive decline, schizophrenia etc. etc..
Patent NZ-608500-A (NZ)
Title: Liquid metering pump, and device for detecting the variation in pressure for such a pump
Inventor: LUCAS GREGORY
IPC: G01L7/08
Filed: 2011-09-28
Abstract: Disclosed is a liquid metering pump with a sensor for detecting the variation in pressure of the fluid flow for improved operational information and problem diagnosis. The liquid metering pump comprises a suction nozzle fitted with an intake valve communicating with a working chamber in which a piston is moved in a reciprocating movement to produce a suction being produced, with opening of the intake valve, and when the piston moves away from the nozzle, a delivery flow is produced, with closure of the intake valve and flow of liquid through an outlet valve, when the piston moves closer to the nozzle. Between the intake valve and the working chamber, there is a pressure-variation detection device that comprises a duct connected to one end of the working chamber and equipped at its other end with the intake valve and, a means sensitive to the pressure in the duct and mounted in the wall of the duct. The means sensitive to the pressure in the duct is connected to means of exploiting the pressure variations detected in order to analyse the operation of the pump. The means of exploiting the pressure variations comprise electronic computation means which are programmed to determine various operating parameters, comprising: to calculate the dosage in real time, the time for which the metering device has been in use, the consumption of chemical product, and the number of breakdowns. The means sensitive to the pressure in the duct comprises a membrane installed on a portion of the wall of the duct and subjected to the pressure emanating from the working chamber, and a detection means detecting movements of the membrane resulting from variations in pressure.
Patent NZ-612298-A (NZ)
Title: Low-temperature synthesis of methylphenidate hydrochloride
Inventor: HUNTLEY C FREDERICK M
IPC: C07D211/34
Filed: 2011-12-16
Abstract: The disclosure relates to a process for the preparation of methylphenidate (Ritalin) or a salt thereof, wherein the esterification process of ritalinic acid and methanol is performed in the presence of an acid catalyst at a low temperature. The acid catalyst may be sulphuric acid, phosphoric acid, hydrogen chloride or hydrogen bromide. The reaction may include adding an orthoester, which may by trimethyl orthoformate or trimethyl orthoacetate and performing the reaction in the presence of a co-solvent. The reaction may also include a crystallisation step.
Patent NZ-622535-A (NZ)
Title: Apparatuses and methods for controlling heat for rapid thermal processing
Inventor: KULPRATHIPANJA SATHIT
IPC: F28F7/00
Filed: 2012-09-14
Abstract: Disclosed is an apparatus for controlling heat for rapid thermal processing of carbonaceous material or wood to produce charcoal. The apparatus comprises a reactor vessel; a reheater in fluid communication with the reactor to receive inorganic heat carrier particles and char. The reheater is configured to form a fluidized bubbling bed that comprises an oxygen-containing gas, the inorganic heat carrier particles, and the char and to operate at combustion conditions effective to burn the char into ash and heat the inorganic heat carrier particles to form heated inorganic particles; An inorganic particle cooler is in fluid communication with the reheater and comprising a shell portion and a tube portion that is disposed in the shell portion. The inorganic particle cooler is configured such that the tube portion receives a portion of the heated inorganic particles and the shell portion receives a cooling medium for indirect heat exchange with the portion of the heated inorganic particles to form first partially-cooled heated inorganic particles that are fluidly communicated to the reheater and a heated cooling medium comprising heated air. The reheater and the inorganic particle cooler are cooperatively configured to combine the first partially-cooled heated inorganic particles with a second portion of the heated inorganic particles in the reheater to form second partially-cooled heated inorganic particles. A dryer that is in fluid communication with the inorganic particle cooler to receive the heated air, and wherein the dryer is configured to receive the carbonaceous material and to remove water from the carbonaceous material with the heated air to form a water-depleted carbonaceous material.
Patent NZ-622719-A (NZ)
Title: Iron-fiber composition, preparation and uses thereof
Inventor: WU-WONG JINSHYUN RUTH
IPC: C07F15/02
Filed: 2012-10-12
Abstract: Disclosed herein are compositions comprising ferrous and/or ferric iron compounds and fiber in a complex, methods for preparing such compositions, and the use thereof for treatment of adsorbing certain accessible targets in the gastrointestinal tract and in an extracorporeal system with minimal iron release that does not affect serum iron levels.
Patent NZ-623421-A (NZ)
Title: Apparatus and method for determining a vehicle feature
Inventor: NAGY OLIVER
IPC: G01S13/00
Filed: 2014-04-09
Abstract: Disclosed is an apparatus (1) for determining a characteristic feature of a vehicle travelling on a roadway. The apparatus (1) includes a detector (8) which is directed towards the roadway and is configured to measure the movement vector of the vehicle at a current location at a current time. A tracking unit (11), connected to the detector (8), calculates a target location of the vehicle at a target time on the basis of current location, current time and movement vector. A first radar sensor (15), connected to the detector (8), transmits a first radar beam (7) directed towards the current location, receives a first reflected radar beam (9) and determines a first frequency spectrum thereof. A second radar sensor (16), connected to the tracking unit (11), transmits a second radar beam (11), directed towards the target location, at the target time, receives a second reflected radar beam (14) and determines a second frequency spectrum thereof. An evaluation unit (19) for generates the characteristic feature of the vehicle from the determined frequency spectra, wherein the determined frequency spectra constitute the characteristic feature of the vehicle.
Patent NZ-701811-A (NZ)
Title: Connection assembly for ground engaging tools
Inventor: HUGHES BENJAMIN
IPC: E02F9/28
Filed: 2011-12-07
Abstract: A lock 100 for a ground engaging tooth 70 mounted onto a base, the lock 100 having at least two positions a first position in which the tooth 70 is able to be coupled to the base, and a second position in which the lock 100 urges the tooth 70 away from the base.
Patent NZ-705919-A (NZ)
Title: Compositions and methods for the removal of phosphates and other contaminants from aqueous solutions
Inventor: ODOM STEVEN
IPC: C04B28/18
Filed: 2013-08-29
Abstract: The invention provides a method of producing a composition capable of removing phosphates, nitrates and heavy metals from a solution, comprising: (a) forming a slurry comprising calcium oxide, silicon dioxide, an alkali and a solvent, wherein the molar ratio of the calcium oxide : the silicon dioxide : the alkali ranges from 2.43-2.97: 1.12-1.38: 0.9-1.1; and (b) producing the composition capable of removing phosphates, nitrates and heavy metals from a solution by subjecting the slurry to a hydrothermal process for about 1 to about 6 hours under about 13.5 to 16.5 psi (93.08 to 113.76 kPa) of pressure. The invention also provides compositions, including a composition characterised by the XRD spectrum in the accompanying Figure. The invention further provides a method of removing phosphates, nitrates and/or heavy metals from a solution, comprising contacting and reacting a composition according to the invention with a solution containing phosphates, nitrates and/or heavy metals.
Patent NZ-707171-A (NZ)
Title: Bis(fluoroalkyl)-1,4-benzodiazepinone compounds as notch inhibitors
Inventor: FINK BRIAN E
IPC: C07F9/38
Filed: 2013-09-20
Abstract: Disclosed are compounds of Formula (I) and/or salts thereof: (I) wherein R1 is CH2CH2CF3; R2 is CH2CH2CF3 or CH2CH2CH2CF3; R3 is H, CH3, or Rx; R4 is H or Ry; Ring A is phenyl or pyridinyl; and Rx, Ry, Ra, Rb, y, and z are defined herein. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer; or as prodrugs of such compounds.
Patent NZ-729507-A (NZ)
Title: Highly potent acid alpha-glucosidase with enhanced carbohydrates
Inventor: DO HUNG
IPC: C12N5/07
Filed: 2015-09-30
Abstract: Recombinant human alpha glucosidase (rhGAA) composition derived from CHO cells that contains a more optimized glycan composition consisting of a higher amount of rhGAA containing N-glycans carrying mannose-6-phosphate (M6P) or bis-M6P than conventional rhGAAs, along with low amount of non-phosphorylated high mannose glycans, and low amount of terminal galactose on complex oligosaccharides. Compositions containing the rhGAA, and methods of use are described.
Patent NZ-748901-A (NZ)
Title: Treatment of keratin-containing biological materials
Inventor: DIAS SUBASINGHE NISSANKE GEORGE PREMALAL JAYANTHA
IPC: A23J1/10
Filed: 2017-05-02
Abstract: The present invention provides methods for extraction of amino acid-rich fractions from keratin-containing biological materials, and to amino acid-rich protein fractions generated by the methods described herein. The methods involve forming a reaction mixture with keratin containing material at a pH of 1.1 to 6.9. The reaction mixture is exposed to an energy source, such as microwaves, sufficient to degrade the keratin. The amino acid mixture which is subsequently extracted is substantially insoluble.